Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism - Université de Bretagne Occidentale Access content directly
Journal Articles Human & Veterinary Medecine Bioflux Year : 2015

Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism

Domains

Immunology

Geneviève Michel  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-01260185

Submitted on : Thursday, January 21, 2016-4:11:10 PM

Last modification on : Thursday, August 3, 2023-1:34:05 PM

No file

Dates and versions

hal-01260185 , version 1 (21-01-2016)

Identifiers

  • HAL Id : hal-01260185 , version 1

Cite

Cristina Bagacean, Naelle Lombion, Adrian Tempescul, Jean-Christophe Ianotto, Christian Berthou, et al.. Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism. Human & Veterinary Medecine Bioflux, 2015, 7 (4), pp.298-301. ⟨hal-01260185⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST IMMUNO
54 View
0 Download

Share

Gmail Facebook X LinkedIn More